[HTML] nature.com

[HTML][HTML] Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

Y Zhu, L Zeng, X Xie, A Morinibu, K Shinomiya… - British journal of …, 2009 - nature.com
Abstract Hypoxia-inducible factor-1 (HIF-1) has been reported to promote tumour
radioresistance; therefore, it is recognised as an excellent target during radiation therapy …
被引用次数：97 相关文章
[PDF] researchgate.net

[PDF][PDF] Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

H Harada, S Itasaka, Y Zhu, L Zeng, X Xie… - British Journal of …, 2009 - researchgate.net
Hypoxia-inducible factor-1 (HIF-1) has been reported to promote tumour radioresistance;
therefore, it is recognised as an excellent target during radiation therapy. However, the …

[引用][C] Treatment regimen determines whether an HIF-I inhibitor enhances or inhibits the effect of radiation therapy

H HARADA, S ITASAKA, Y ZHU, L ZENG… - British journal of …, 2009 - pascal-francis.inist.fr
Treatment regimen determines whether an HIF-I inhibitor enhances or inhibits the effect of
radiation therapy CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

[引用][C] Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

H Harada, S Itasaka, Y Zhu, L Zeng, X Xie… - British Journal of …, 2009 - cir.nii.ac.jp

Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy.

H Harada, S Itasaka, Y Zhu, L Zeng, X Xie… - British Journal of …, 2009 - europepmc.org
Abstract Hypoxia-inducible factor-1 (HIF-1) has been reported to promote tumour
radioresistance; therefore, it is recognised as an excellent target during radiation therapy …
[HTML] nih.gov

[HTML][HTML] Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

H Harada, S Itasaka, Y Zhu, L Zeng, X Xie… - British Journal of …, 2009 - ncbi.nlm.nih.gov
Abstract Hypoxia-inducible factor-1 (HIF-1) has been reported to promote tumour
radioresistance; therefore, it is recognised as an excellent target during radiation therapy …

Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy.

H Harada, S Itasaka, Y Zhu, L Zeng… - British Journal of …, 2009 - search.ebscohost.com
Abstract Hypoxia-inducible factor-1 (HIF-1) has been reported to promote tumour
radioresistance; therefore, it is recognised as an excellent target during radiation therapy …

Treatment regimen determines whether a HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

H HARADA, S ITASAKA, M HIRAOKA - The Japan Radiation …, 2009 - jstage.jst.go.jp
抄録 HIF-1 抑制剤が放射線治療の効果を増感することが報告されている. その一方で, HIF-1
活性の阻害は腫瘍血管密度の減少を引き起こし, 結果として放射線抵抗性の低酸素分画を増大 …
[PDF] psu.edu

[PDF][PDF] Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

H Harada, S Itasaka, Y Zhu, L Zeng, X Xie… - British Journal of …, 2009 - Citeseer
Hypoxia-inducible factor-1 (HIF-1) has been reported to promote tumour radioresistance;
therefore, it is recognised as an excellent target during radiation therapy. However, the …

Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy

H Harada, S Itasaka, Y Zhu, L Zeng… - British journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
Hypoxia-inducible factor-1 (HIF-1) has been reported to promote tumour radioresistance;
therefore, it is recognised as an excellent target during radiation therapy. However, the …